| Literature DB >> 20840763 |
Andrew S Wieczorek1, Vincent J J Martin.
Abstract
BACKGROUND: The assembly and spatial organization of enzymes in naturally occurring multi-protein complexes is of paramount importance for the efficient degradation of complex polymers and biosynthesis of valuable products. The degradation of cellulose into fermentable sugars by Clostridium thermocellum is achieved by means of a multi-protein "cellulosome" complex. Assembled via dockerin-cohesin interactions, the cellulosome is associated with the cell surface during cellulose hydrolysis, forming ternary cellulose-enzyme-microbe complexes for enhanced activity and synergy. The assembly of recombinant cell surface displayed cellulosome-inspired complexes in surrogate microbes is highly desirable. The model organism Lactococcus lactis is of particular interest as it has been metabolically engineered to produce a variety of commodity chemicals including lactic acid and bioactive compounds, and can efficiently secrete an array of recombinant proteins and enzymes of varying sizes.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20840763 PMCID: PMC2949795 DOI: 10.1186/1475-2859-9-69
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Figure 1pAW series of expression vectors and strategy for complex assembly. (A) Vectors were designed for facilitated insertion of fragments of the gene encoding the cellulosomal scaffold protein CipA, into AscI-NotI restriction sites. Scaffolds can be optionally expressed with or without an N-terminal nuclease reporter and/or a C-terminal cell wall anchor motif. pAW304 is designed for expression, secretion, and cell wall-targeting of CipA fragments (CipAfrags) as fusions with the N-terminal NucA reporter. pAW305 is designed for the expression and secretion of CipAfrags as a fusion with the N-terminal NucA reporter, but without the C-terminal anchor motif. pAW504 is designed for expression, secretion, and cell wall-targeting of CipAfrags without the N-terminal NucA reporter. pAW505 is designed for the expression and secretion of CipAfrags with neither the N-terminal NucA reporter nor the C-terminal anchor motif. (B) Graphic depiction of the surface-display strategy of engineered scaffolds and their association with the β-glucuronidase-dockerin fusion protein (UidA-dock1). All successfully displayed CipAfrags are portrayed as fusions with both NucA and a cell wall anchor, however were also expressed and tested without these two components.
Figure 2Growth profiles of . Panels A, D and G represent cultures not induced with nisin, panels B, E, H represent cultures induced with 10 ng/mL nisin at inoculation (t = 0 hrs), and panels C, F, I represent cultures induced with 10 ng/mL nisin in log phase corresponding to an OD600 ≈ 0.3 (t = 4 hrs). Constructs were grouped according to their modular nature. Top panels depict constructs containing a single cohesin; Middle panels depict constructs containing two CipA modules; Lower panels depict constructs containing no cohesin modules. Black shapes indicate scaffolds containing a fusion with NucA, and white shapes indicate scaffolds where NucA has been removed. Solid lines represent scaffolds expressed with a cell wall anchor, and dotted lines represent scaffolds lacking the cell wall anchor. Experiments were repeated three times yielding identical trends between growth profiles.
Figure 3Cellular localization of NucA-CipA. NucA activity was detected by spotting cell fractions on TBD-agar and analyzing for pink color formation. Fractions analyzed are supernatant (sup), cell wall (cw), and cytoplasm (cyt). Constructs are represented by their respective CipAfrag components and were expressed as fusions with NucA with or without cell wall anchor (cwa) domains.
Figure 4. CipAfrags were expressed and anchored as fusions with the NucA reporter enzyme (A), or lacking the NucA reporter (B). Quantification of UidAdock1 molecules bound to L. lactis cells corresponds to equivalent amounts of functional cohesin assuming a 1:1 ratio of dockerin-cohesin association. Dark grey bars represent scaffolds containing the C-terminal M6 cell wall anchor motif (cwa), and light grey bars represent their anchor-deficient derivatives. White bars correspond to indicated controls; "200 μg/mL UidA-dock1" represents binding assay carried out with excess enzyme and L. lactis pAW328 (NucA-CBM3a-coh3-cwa) to ensure saturation of cohesins. "100 μg/mL UidA" represents binding assay carried out in the presence of UidA and L. lactis pAW328 (NucA-CBM3a-cwa). Binding assay carried out with UidA and all other constructs resulted in no association with scaffold-expressing strains (data not shown).
Strains and plasmids used in this study.
| Strain | Genotype/Decription | Source |
|---|---|---|
| MG1363 ( | [ | |
| ATCC | ||
| Invitrogen | ||
| Novagen | ||
| pVE5524 | Eryr, Ampr; pBS::pIL252:: | [ |
| pVE5523 | Eryr, Ampr; pBS::pIL252:: | [ |
| pSIP502 | Eryr; | [ |
| pSCNIII | Cmr | J. Seegers |
| pUC19 | Ampr | [ |
| pET28(b) | Kmr | Novagen |
| pSIPsp-nuc | Eryr; | This Work |
| pUC104 | Ampr; | This Work |
| pUC104mod | Ampr; | This Work |
| pUC304 | Ampr; | This Work |
| pUC504 | Ampr; | This Work |
| pAW004 | Eryr, Ampr; pBS::pIL252:: | This Work |
| pAW005 | Eryr, Ampr; pBS::pIL252:: | This Work |
| pAW004Z | Eryr, Ampr; pBS::pIL252:: | This Work |
| pAW005Z | Eryr, Ampr; pBS::pIL252:: | This Work |
| pAW004ZC | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW005ZC | Cmr, Ampr; pBS::pIL252:: | This Work |
| pGEMc9 | Ampr; pGEMT::with cloned | This Work |
| pGEMc1 | Ampr; pGEMT::with cloned | This Work |
| pGEMc1-c2 | Ampr; pGEMT::with cloned | This Work |
| pGEMcbm-c3 | Ampr; pGEMT::with cloned | This Work |
| pGEMcbm | Ampr; pGEMT::with cloned | This Work |
| pAW104 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW105 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW301 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW302 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW304 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW305 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW307 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW308 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW310 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW311 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW334 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW335 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW328 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW329 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW331 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW332 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW504 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW505 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW507 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW508 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW510 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW511 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW534 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW535 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW528 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW529 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW531 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pAW532 | Cmr, Ampr; pBS::pIL252:: | This Work |
| pETdock1 | Knr; pET28(b)::with cloned | This Work |
| pETUdock1 | Knr; pET28(b):: | This Work |
| pETU | Knr; pET28(b):: | This Work |
Vector pSCNIII was a gift provided by Jos Seegers (unpublished data)
pAW100 series of vectors are nisin-inducible and contain an intact rbs. pAW300 series vectors are nisin-inducible and contain an intact rbs. pAW500 series vectors are pAW300 variants lacking an N-terminal NucA fusion. P59, constitutive lactococcal promoter; PT7, inducible T7 promoter; P, inducible nisA promoter; rbs, Usp45 ribosome-binding site; rbs, nisA ribosome-binding site; spUsp45, signal sequence of Usp45; nucA, staphylococcal nuclease; cwaM6, anchor motif of M6 protein; llt2, transcriptional terminator of rrnB operon; t, transcriptional terminator of trpA.
Primers used in this study.
| Primer | Sequence (5'-3') |
|---|---|
| TAT | |
| AT | |
| TAGATATC | |
| TAGCTAGC | |
| GATCTAGC | |
| CGTAGATC | |
| TCGA | |
| TCGA | |
| TA | |
| TA | |
| TCGA | |
| TCGA | |
| TCGA | |
| TGA | |
| ATGC | |
| ATGTAC | |
| AGAACAG | |
| ATAT | |
| AGTC | |
| ATGC | |
| GCTT | |
| GCTT | |
| ATGC |
Restriction enzyme cut sites are in bold.